You Might Also Like: Science Will Win

Introducing Live from SXSW - Outdoing Cancer Is A Team Sport from Science Will Win. Follow the show: Science Will Win While cancer deaths in the United States have declined in recent years, some populations are being left behind—facing complicated challenges to accessing the care they need. Intervening at the earliest stages of disease onset is critical to cancer treatment success and to reducing the risk of recurrence. So how do we create a world where all people with cancer are quickly diagnosed and can live better, longer lives as science advances? In this conversation, patient advocates and healthcare leaders from Pfizer, the American Cancer Society, and the Healthcare Businesswomen’s Association, discuss the power of collaboration in the effort to “Outdo Cancer.” Moderator • Tyrone McClain, Senior Director, Public Affairs, Pfizer Speakers • Carmen White, U.S. & Global Oncology Health Equity Lead, Pfizer • Pam Traxel, American Cancer Society, Cancer Action Network • Mary Stutts, CEO, Healthcare Businesswomen's Association (HBA) This episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.